http://ijpr.sbmu.ac.ir/
Preparation and characterization of rifampin loaded ... - Europe PMC
WebMay 27, 2024 · The Iranian Journal of Pharmaceutical Research (IJPR) is a peer-reviewed multi-disciplinary pharmaceutical publication, scheduled to appear quarterly and serve as a means for scientific information exchange in the international pharmaceutical forum. The Journal, particularly welcomes contribution relevant to the Middle East region. WebIranian Journal of Pharmaceutical Research (2013), 12 (3): 503-509 Received: October 2012 Accepted: February 2013 * Corresponding author: E-mail: [email protected] Introduction Antibiotic resistance is a major and increasing problem in the arena of infectious diseases as a whole and in the therapy of hospital infections in particular (1-3). rdof grant map
Comparison of Mirtazapine and Olanzapine on Nausea …
WebIran J Pharm Res.2016 Winter; 15(Suppl): 149–157. PMCID: PMC5242360 PMID: 28228812 A Wound Healing Formulation Based on Iranian Traditional Medicine and Its HPTLC Fingerprint Maryam Jahandideh,a,bHoma Hajimehdipoor,bSeyed Alireza Mortazavi,c,*Ahmadreza Dehpour,d,eand Gholamreza Hassanzadehf Maryam Jahandideh WebIranian Journal of Pharmaceutical Research Articles in Press Current Issue Journal Archive Announcement: " Briefland is the new publisher of IJPR; beginning from 2024" Please Do … Instructions for Authors updated September 2024. Introduction . The Iranian Journal … Reviewers - Iranian Journal of Pharmaceutical Research Contact Us - Iranian Journal of Pharmaceutical Research Login - Iranian Journal of Pharmaceutical Research Register - Iranian Journal of Pharmaceutical Research Current Issue - Iranian Journal of Pharmaceutical Research By Issue - Iranian Journal of Pharmaceutical Research By Author - Iranian Journal of Pharmaceutical Research By Subject - Iranian Journal of Pharmaceutical Research Author Index - Iranian Journal of Pharmaceutical Research WebIran J Pharm Res. 2016 Autumn; 15 (4): 783–790. PMCID: PMC5316256 PMID: 28243274 Novel Thiazolidinone-Azole Hybrids: Design, Synthesis and Antimycobacterial Activity Studies Barbaros Eroglu, a Keriman Ozadali-Sari, a,* Oya Unsal-Tan, a Sriram Dharmarajan, b Perumal Yogeeswari, b and Ayla Balkan a rdof long form